Related Experiment Videos
Postpartum myocardial infarction in a patient receiving bromocriptine
1Department of Obstetrics and Gynecology, Medical College of Ohio, Toledo.
Obstetrics and Gynecology
|September 1, 1989
Summary
Postpartum myocardial infarction can occur in women with a history of pregnancy-induced hypertension. Bromocriptine may play a role in coronary artery vasospasm, warranting further investigation into this serious cardiac event.
Area of Science:
- Cardiology
- Obstetrics
- Pharmacology
Background:
- Postpartum myocardial infarction (PMI) is a rare but serious complication.
- Pregnancy-induced hypertension (PIH) is a known risk factor for cardiovascular events.
- Lactation suppression with bromocriptine is a common postpartum practice.
Observation:
- A 27-year-old multiparous woman presented with severe hypertension and cardiac arrest 10 days postpartum.
- Coronary catheterization revealed significant stenosis in the left anterior descending artery, suggestive of coronary artery spasm.
- The patient had a history of PIH and was prescribed bromocriptine for lactation suppression.
Findings:
- Review of reported PMI cases indicates a strong association with a history of PIH.
- Coronary artery spasm is a potential underlying mechanism for PMI in this population.
- The role of bromocriptine, an ergot derivative, in exacerbating vasospasm requires consideration.
Implications:
- Identifying risk factors like PIH is crucial for early detection and prevention of PMI.
- Further research is needed to elucidate the link between bromocriptine, vasospasm, and PMI.
- This case highlights the importance of considering cardiovascular complications in the postpartum period, especially in high-risk individuals.